O'Shaughnessy Asset Management’s OptimizeRx OPRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-711	Closed	-$61K	–	2089
2021 Q3	$61K	Hold	711	–	–	﹤0.01%	1570
2021 Q2	$44K	Hold	711	–	–	﹤0.01%	1630
2021 Q1	$35K	Hold	711	–	–	﹤0.01%	1512
2020 Q4	$22K	Buy	+711	New	+$17.4K	﹤0.01%	1400

Other funds holding OPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

O'Shaughnessy Asset Management's OPRX Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of OptimizeRx (OPRX) in Q4 2021, closing a stake of 711 shares — an estimated $61K sold.

O'Shaughnessy Asset Management first reported a position in OPRX in Q4 2020 and held it in 4 quarters. The position peaked at $61K in Q3 2021. 180 funds tracked by Wall St. Rank hold OPRX as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining OptimizeRx position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 711 OptimizeRx shares in Q4 2021, an estimated $61K.
O'Shaughnessy Asset Management first reported a position in OptimizeRx in Q4 2020 and held it in 4 quarters.
O'Shaughnessy Asset Management's OptimizeRx position peaked at $61K in Q3 2021.
180 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.